glp-1-based treatments approved for weight loss 2025 GLP-1 Agonists Drugs Market Report, 2025-2030 Weight-loss drugs such as Ozempic

In a dry environment (constipation), it absorbs water and softens stool

Peer-reviewed data on optimal maintenance dosing remains limited, though real-world registry analyses suggest that partial dose reduction can retain 70 to 80% of weight loss in selected patients

IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness

An exploratory analysis of those formerly using insulin in conjunction with GLP-1 receptor agonist (who were originally excluded from the main analysis) showed an increase in HbA1c (1.2%1.3%, P =0.006) (Supplemental Table S1), suggesting that the insulin dose adjustments made after discontinuing GLP-1 receptor agonists were insufficient to maintain glycemic control

Nat Cancer

The particle stack of semaglutide and taspoglutide-GLP-1R-Gs complexes from RELION consensus refinement were imported into the cryoSPARC environment